Changes in Nonsteroidal Immunosuppressive Treatment Usage Before and After Efgartigimod Initiation in Patients with Myasthenia Gravis (P1-11.015)
To evaluate changes in utilization of nonsteroidal immunosuppressive treatments (NSISTs) before and after efgartigimod initiation in patients with myasthenia gravis (MG).
Authors
- Matt Jefferson
- Neelam Goyal
- Pushpa Narayanaswami (ORCID: https://orcid.org/0000-0002-9412-7349)
- Arash Mahajerin (ORCID: https://orcid.org/0000-0002-0549-0155)
- R. W. F. Campbell
- Rohit Kunnath Menon (ORCID: https://orcid.org/0000-0002-7486-8721)
- S. Selvaraj (ORCID: https://orcid.org/0000-0001-7363-2816)
- Gil I. Wolfe (ORCID: https://orcid.org/0000-0003-1471-9617)
- Cynthia Z. Qi (ORCID: https://orcid.org/0009-0007-9096-3570)
- Mai Sato (ORCID: https://orcid.org/0000-0001-9620-3483)
- A. Gordon Smith
Institutions
- Hadassah Medical Center (IL)
- University of Miami Health System (US)
- Argenx (Belgium) (BE)
- University at Buffalo, State University of New York (US)
- Stanford University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211398
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00